


The Endemic Coronaviruses and What They Might Tell us About COVID-19
While less-well known than some of their counterparts, the 229E, NL63, OC43, and HKU1 human coronaviruses are a significant cause of respiratory disease worldwide. The evolutionary histories and host associations of the endemic coronaviruses also provide important...
A Q&A with David Flavell of Leukaemia Busters
In this blog, we speak with Dr. David Flavell about his scientific career, the legacy of Leukaemia Busters, and the recent impact that COVID-19 has had on his research. Tell me about your scientific background David. I was born in a seaside town called Southport in...
Avoiding the Immunopathology Pitfalls of a COVID-19 Vaccine
In the second of a three-part series on COVID-19 vaccines, we explore the potential challenges in stimulating safe vaccine responses and outline the role that diagnostics will play in guiding their development. Rogue Responses Antibodies play a crucial role in...
The Bumpy Road to a Cytomegalovirus Vaccine
The development of a cytomegalovirus vaccine has been 50 years in the making. Are there any technologies in the pipeline that could prompt a breakthrough? This article was originally posted online at The Medicine Maker, a Texere publication. To say that...